{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:02:51Z","timestamp":1794254571433,"version":"4.9.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41577-020-00451-5","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T13:32:54Z","timestamp":1599744774000},"page":"583-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":446,"title":["COVID-19 herd immunity: where are we?"],"prefix":"10.1038","volume":"20","author":[{"given":"Arnaud","family":"Fontanet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cauchemez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"451_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"H Salje","year":"2020","unstructured":"Salje, H. et al. Estimating the burden of SARS-CoV-2 in France. Science 369, 208\u2013211 (2020).","journal-title":"Science"},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1126\/science.abc6810","volume":"369","author":"T Britton","year":"2020","unstructured":"Britton, T., Ball, F. & Trapman, P. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2. Science 369, 846\u2013849 (2020).","journal-title":"Science"},{"key":"451_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.19.20157362","author":"E Goldstein","year":"2020","unstructured":"Goldstein, E., Lipsitch, M. & Cevik, M. On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.07.19.20157362 (2020).","journal-title":"medRxiv"},{"key":"451_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.13.20153163","author":"O Byambasuren","year":"2020","unstructured":"Byambasuren, O. et al. Estimating the seroprevalence of SARS-CoV-2 infections: systematic review. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.07.13.20153163 (2020).","journal-title":"medRxiv"},{"key":"451_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","volume":"584","author":"S Flaxman","year":"2020","unstructured":"Flaxman, S. et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584, 257\u2013261 (2020).","journal-title":"Nature"},{"key":"451_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.017","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.08.017 (2020).","journal-title":"Cell"},{"key":"451_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","volume":"20","author":"A Sette","year":"2020","unstructured":"Sette, A. & Crotty, S. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nat. Rev. Immunol. 20, 457\u2013458 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"451_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.29.20142596","author":"I Sermet-Gaudelus","year":"2020","unstructured":"Sermet-Gaudelus, I. et al. Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated multisystem inflammatory syndrome in children. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.06.29.20142596 (2020).","journal-title":"medRxiv"},{"key":"451_CR9","unstructured":"Service de sant\u00e9 des arm\u00e9es. Investigation de l\u2019\u00e9pid\u00e9mie de COVID-19 au sein du Groupe A\u00e9ronaval. Service de sant\u00e9 des arm\u00e9es https:\/\/www.defense.gouv.fr\/content\/download\/583466\/9938746\/file\/20200405_929_ARM_SSA_CESPA_rapport_epidemie_covid19_Gan_VEXP.pdf (2020)."},{"key":"451_CR10","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1056\/NEJMp0903906","volume":"360","author":"MA Miller","year":"2009","unstructured":"Miller, M. A., Viboud, C., Balinska, M. & Simonsen, S. The signature features of influenza pandemics \u2014 implications for policy. N. Engl. J. Med. 360, 2595\u20132598 (2009).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00451-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00451-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00451-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T23:30:53Z","timestamp":1631143853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00451-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-00451-5","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"9 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.F. and S.C. are members of the COVID-19 Scientific Council advising the French Ministry of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}